Overall survival in renal-cell carcinoma with pazopanib versus sunitinib Journal Article


Authors: Motzer, R. J.; Hutson, T. E.; McCann, L.; Deen, K.; Choueiri, T. K.
Article Title: Overall survival in renal-cell carcinoma with pazopanib versus sunitinib
Keywords: controlled study; disease-free survival; mortality; angiogenesis inhibitor; sunitinib; disease free survival; follow up; follow-up studies; letter; controlled clinical trial; randomized controlled trial; pyrimidines; kidney carcinoma; kidney neoplasms; kidney tumor; carcinoma, renal cell; sulfonamide; sulfonamides; pazopanib; phase 3 clinical trial; kaplan meier method; indoles; pyrroles; pyrimidine derivative; angiogenesis inhibitors; indole derivative; pyrrole derivative; kaplan-meier estimate; humans; human
Journal Title: New England Journal of Medicine
Volume: 370
Issue: 18
ISSN: 0028-4793
Publisher: Massachusetts Medical Society  
Date Published: 2014-05-01
Start Page: 1769
End Page: 1770
Language: English
DOI: 10.1056/NEJMc1400731C2-24785224
PROVIDER: scopus
PUBMED: 24785224
DOI/URL:
Notes: New Engl. J. Med. -- Export Date: 2 June 2014 -- CODEN: NEJMA -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Robert Motzer
    1243 Motzer